癌变·畸变·突变 ›› 2024, Vol. 36 ›› Issue (3): 169-171.doi: 10.3969/j.issn.1004-616x.2024.03.001

• 专家述评 •    下一篇

衰老与恶性肿瘤——被忽视的免疫衰老

张开泰   

  1. 中国医学科学院肿瘤医院/国家癌症中心, 北京 100021
  • 收稿日期:2024-03-27 修回日期:2024-04-07 出版日期:2024-05-30 发布日期:2024-06-05
  • 作者简介:张开泰,男,中国医学科学院肿瘤医院/国家癌症中心研究员,北京协和医学院博士生导师。研究领域包括恶性肿瘤免疫衰老、循环肿瘤细胞早期检测及转移机制,溶瘤病毒抗肿瘤免疫研究。E-mail:zhangkt@cicams.ac.cn

Aging and malignant tumors—the neglected immunosenescence

ZHANG Kaitai   

  1. Cancer Hospital, Chinese Academy of Medical Sciences/National Cancer Center, Beijing 100021, China
  • Received:2024-03-27 Revised:2024-04-07 Online:2024-05-30 Published:2024-06-05

摘要: 免疫衰老是人体自然衰老的一部分,也是影响整体衰老进程的关键环节。恶性肿瘤作为老年性疾病,普遍存在严重的免疫衰老现象。除免疫系统的自然衰老外,肿瘤细胞可进一步加速免疫衰老,导致免疫系统年轻细胞减少,老化细胞增多,抗肿瘤免疫功能低下。阻断恶性肿瘤与免疫衰老的相互诱导,逆转免疫衰老对于控制肿瘤、实现长期带瘤生存具有积极意义。

关键词: 恶性肿瘤, 免疫衰老, 带瘤生存, 老化细胞

Abstract: Immunosenescence is an inherent and crucial aspect of the aging process. Malignant tumors which often develop among senior individuals are associated with immunosenescence. Besides the immune system's intrinsic aging,cancerous cells can exacerbate immunosenescence. This combination can lead to a reduction of young immune cells and an increase of older immune cells. Consequently,the immune system would have reduced ability to combat tumors. Interrupting the reciprocal interaction between malignant tumors and immunosenescence,as well as reversing the effects of immunosenescence,can hold promise for enhancing antitumor responses and improving long-term survival of cancer patients.

Key words: malignant tumors, immunosenescence, survive with tumor, eged cell

中图分类号: